Here's Why ClearBridge SMID Cap Growth Strategy Exited Stevanato (STVN)
Stevanato Group Enters Strategic Industry Alliance
SCHOTT Pharma, Gerresheimer, and Stevanato Form Alliance, Push RTU Solutions For Pharma Efficiency
Do Fundamentals Have Any Role To Play In Driving Stevanato Group S.p.A.'s (NYSE:STVN) Stock Up Recently?
Should You Hold Stevanato Group S.p.A. (STVN)?
S&P 500 Futures Steady In Premarket Trading; Credo Tech Group, Frontier Comms Parent Lag
Ambarella, Bill Holdings And Box Are Among Top 7 Mid Cap Gainers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?
Stevanato Group to Present at Upcoming Investor Conferences
Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday
Analysts Offer Insights on Healthcare Companies: Silence Therapeutics (SLN), Pharvaris (PHVS) and Stevanato Group (STVN)
Morgan Stanley Sticks to Its Hold Rating for Stevanato Group (STVN)
Multiple Factors Pulled Down Stevanato Group S.p.A. (STVN) Shares in Q2
Morgan Stanley Maintains Stevanato Group(STVN.US) With Hold Rating, Maintains Target Price $22
Morgan Stanley Remains a Hold on Stevanato Group (STVN)
Stevanato Group SpA (STVN) Fell on Disappointing Quarter and Reduced Guidance
Stevanato Group Navigates Q2 Challenges, Optimistic on Growth
Weak Statutory Earnings May Not Tell The Whole Story For Stevanato Group (NYSE:STVN)
Stevanato Group S.p.A. Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next
Stevanato Group Price Target Cut to $28.00/Share From $30.00 by Citigroup
Stevanato Group Is Maintained at Buy by Citigroup